← FDA Drug Approvals (Drugs@FDA)

APRESOLINE

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 1953-01-15

Drug application

FDA Application #

NDA008303

Application type

New Drug Application

Brand name

APRESOLINE

Generic name

Hydralazine Hydrochloride

Active ingredients

HYDRALAZINE HYDROCHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

NOVARTIS

First approval

1953-01-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown